News & Updates

Statin confers cardioprotection, survival benefit for middle-aged, older diabetics
Statin confers cardioprotection, survival benefit for middle-aged, older diabetics
14 Nov 2021

Statin reduces the risk of cardiovascular disease and mortality in type 2 diabetes, and this beneficial effect is evident among middle-aged and, to a lesser extent, older patients but not among young patients, a study has found.

Statin confers cardioprotection, survival benefit for middle-aged, older diabetics
14 Nov 2021
Medicine uptitration amps up RDN benefit for drug-resistant hypertension
Medicine uptitration amps up RDN benefit for drug-resistant hypertension
14 Nov 2021 byAudrey Abella

In patients with multidrug-resistant hypertension (HTN), the blood pressure (BP)-lowering benefit of renal denervation (RDN) achieved at 2 months was amplified when a stepped-care medication escalation protocol was added between 2 and 6 months, updates from the RADIANCE-HTN TRIO trial have shown.

Medicine uptitration amps up RDN benefit for drug-resistant hypertension
14 Nov 2021